Clinical Trial Update: Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing telmisartan fixed-dose combination against amlodipine in hypertensive patients with type 2 diabetes mellitus completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• MICARDIS HCT (Telmisartan and hydrochlorothiazide)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-07